Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation-Reference-Cited by-同舟云学术

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation

Published:2017-05-19 Issue:9 Volume:40 Page:746-751
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Black‐Maier Eric¹,Kim Sunghee²,Steinberg Benjamin A.¹²^ORCID,Fonarow Gregg C.³^ORCID,Freeman James V.⁴,Kowey Peter R.⁵,Ansell Jack⁶,Gersh Bernard J.⁷,Mahaffey Kenneth W.⁸,Naccarelli Gerald⁹,Hylek Elaine M.¹⁰,Go Alan S.¹¹,Peterson Eric D.¹²,Piccini Jonathan P.¹²,

Affiliation:

1. Cardiac Electrophysiology Section, Duke Center for Atrial FibrillationDuke Clinical Research Institute, Duke University Medical Center Durham North Carolina

2. Duke Clinical Research Institute Durham North Carolina

3. Division of CardiologyUniversity of California Los Angeles Los Angeles California

4. Department of CardiologyYale University School of Medicine New Haven Connecticut

5. Department of CardiologyLankenau Hospital and Medical Research Center Philadelphia Pennsylvania

6. Department of Cardiology, New York University School of MedicineLenox Hill Hospital New York New York

7. Division of Cardiovascular DiseasesMayo Clinic Rochester Minnesota

8. Department of CardiologyStanford University School of Medicine Palo Alto California

9. Department of CardiologyPenn State University School of Medicine Hershey Pennsylvania

10. Department of CardiologyBoston University School of Medicine Boston Massachusetts

11. Division of ResearchKaiser Permanente Oakland California

Funder

Janssen Scientific Affairs

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.22726

Reference16 articles.

1. Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

2. Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

3. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial

4. Post-operative use of heparin increases morbidity of pacemaker implantation

5. Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulant therapy during cardiovascular implantable electronic device procedures;Advances in Interventional Cardiology;2023

2. Periprocedural anticoagulation therapy in patients undergoing micra leadless pacemaker implantation;International Journal of Cardiology;2023-01

3. Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs;International Journal of Environmental Research and Public Health;2022-09-21

4. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper;Thrombosis and Haemostasis;2022-07-06

5. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society;EP Europace;2022-03-22